Peripubertal Diazepam Administration Prevents the Emergence of Dopamine System Hyperresponsivity in the MAM Developmental Disruption Model of Schizophrenia

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892

Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies

Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356

Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States

Yung, A. R., Yung, A. R., Yuen, H. P., McGorry, P. D., Phillips, L., Kelly, D., Dell’Olio, M., Francey, S. M., Cosgrave, E., Killackey, E. J., et al. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01714.x · Cited by 2,284

Prodromal Assessment With the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive Validity, Interrater Reliability, and Training to Reliability

Miller, T. J., McGlashan, T. H., Rosen, J. L., Cadenhead, K. S., Ventura, J., McFarlane, W. R., Perkins, D. O., Pearlson, G. D., & Woods, S. W. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007040 · Cited by 1,800

Cortisol levels during human aging predict hippocampal atrophy and memory deficits

Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P. V., Thakur, M., McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998) · Nature Neuroscience · doi:10.1038/271 · Cited by 1,653

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia

Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.004 · Cited by 1,071

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization

Grace, A. A., & Bunney, B. S. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90135-5 · Cited by 937

Schizophrenia: A neural diathesis-stress model.

Walker, E. F., & Diforio, D. (1997) · Psychological Review · doi:10.1037//0033-295x.104.4.667 · Cited by 930

Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors

Magarin˜os, A. M., & McEwen, B. S. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00259-l · Cited by 863

Hippocampal Volume Reduction in Schizophrenia as Assessed by Magnetic Resonance Imaging

Nelson, M. D., Saykin, A. J., Flashman, L. A., & Riordan, H. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.5.433 · Cited by 756

Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression

Grace, A. A. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.57 · Cited by 1,166

Schizophrenia: an integrated sociodevelopmental-cognitive model

Howes, O. D., & Murray, R. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62036-x · Cited by 864

Altering the course of schizophrenia: progress and perspectives

Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516

Developmental timing and critical windows for the treatment of psychiatric disorders

Marín, O. (2016) · Nature Medicine · doi:10.1038/nm.4225 · Cited by 374

Oscillations and Neuronal Dynamics in Schizophrenia: The Search for Basic Symptoms and Translational Opportunities

Uhlhaas, P. J., & Singer, W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.019 · Cited by 243

Translating the MAM model of psychosis to humans

Modinos, G., Allen, P., Grace, A. A., & McGuire, P. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2014.12.005 · Cited by 165

Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia

Do, K. Q., Cuenod, M., & Hensch, T. K. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv065 · Cited by 158

The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention.

Grace, A., & Gomes, F. V. (2019) · Schizophrenia bulletin · doi:10.1093/schbul/sbx199 · Cited by 143

Adolescent Neurodevelopment and Vulnerability to Psychosis

Patel, P. K., Leathem, L. D., Currin, D. L., & Karlsgodt, K. H. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.028 · Cited by 152

Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia

Sonnenschein, S. F., Gomes, F. V., & Grace, A. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00613 · Cited by 138

Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model

Gomes, F. V., Rincón‐Cortés, M., & Grace, A. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.030 · Cited by 131

Stress during critical periods of development and risk for schizophrenia

Gomes, F. V., Zhu, X., & Grace, A. A. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.030 · Cited by 128

Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development

Egerton, A., Grace, A. A., Stone, J. M., Bossong, M. G., Sand, M. S., & McGuire, P. K. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.013 · Cited by 118

Advantages and Limitations of Animal Schizophrenia Models

Białoń, M., & Wąsik, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115968 · Cited by 104

Maternal Immune Activation Disrupts Dopamine System in the Offspring

Luchicchi, A., Lecca, S., Melis, M., Felice, M. D., Cadeddu, F., Frau, R., Muntoni, A. L., Fadda, P., Devoto, P., & Pistis, M. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw007 · Cited by 105

Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

Štark, T., Kučerová, J., Iannotti, F. A., D’Addario, C., Marco, R. D., Pekařík, V., Dražanová, E., Piscitelli, F., Bari, M., Babinská, Z., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.035 · Cited by 90

Prefrontal Cortex Dysfunction Increases Susceptibility to Schizophrenia-Like Changes Induced by Adolescent Stress Exposure

Gomes, F. V., & Grace, A. (2016) · Schizophrenia bulletin · doi:10.1093/schbul/sbw156 · Cited by 84

Adolescent Stress as a Driving Factor for Schizophrenia Development-A Basic Science Perspective.

Gomes, F. V., & Grace, A. (2017) · Schizophrenia bulletin · doi:10.1093/schbul/sbx033 · Cited by 73

Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models

Wegrzyn, D., Juckel, G., & Faissner, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105482 · Cited by 80

Effects of Pubertal Cannabinoid Administration on Attentional Set-Shifting and Dopaminergic Hyper-Responsivity in a Developmental Disruption Model of Schizophrenia

Gomes, F. V., Guimarães, F. S., & Grace, A. A. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu018 · Cited by 68

The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis

Taylor, S. F., Grove, T. B., Ellingrod, V. L., & Tso, I. F. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz046 · Cited by 67

Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

Gomes, F. V., & Grace, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094467 · Cited by 66

Hippocampal circuit dysfunction in psychosis

Knight, S., McCutcheon, R. A., Dwir, D., Grace, A. A., O’Daly, O., McGuire, P. K., & Modinos, G. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02115-5 · Cited by 61

The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia

Uliana, D. L., Lisboa, J. R., Gomes, F. V., & Grace, A. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116298 · Cited by 71

Abnormal Stress Responsivity in a Rodent Developmental Disruption Model of Schizophrenia

Zimmerman, E. C., Bellaire, M., Ewing, S. G., & Grace, A. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.110 · Cited by 66

Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model

Gill, K. M., & Grace, A. A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571400056x · Cited by 60

Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration

Du, Y., & Grace, A. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.42 · Cited by 59

Prospective Analysis of the Effects of Maternal Immune Activation on Rat Cytokines during Pregnancy and Behavior of the Male Offspring Relevant to Schizophrenia

Lins, B. R., Hurtubise, J. L., Roebuck, A. J., Marks, W. N., Zabder, N. K., Scott, G. A., Greba, Q., Dawicki, W., Zhang, X., Rudulier, C. D., et al. (2018) · eNeuro · doi:10.1523/eneuro.0249-18.2018 · Cited by 62

Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis

Modinos, G., Şimşek, F., Azis, M., Bossong, M., Bonoldi, I., Samson, C., Quinn, B., Perez, J., Broome, M., Zelaya, F., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-017-0004-6 · Cited by 62

Schizophrenia — an anxiety disorder?

Hall, J. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.195370 · Cited by 52

Maternal Immune Activation during Pregnancy Alters the Behavior Profile of Female Offspring of Sprague Dawley Rats

Lins, B. R., Marks, W. N., Zabder, N. K., Greba, Q., & Howland, J. G. (2019) · eNeuro · doi:10.1523/eneuro.0437-18.2019 · Cited by 54

Prepubertal Environmental Enrichment Prevents Dopamine Dysregulation and Hippocampal Hyperactivity in MAM Schizophrenia Model Rats

Zhu, X., & Grace, A. A. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.09.023 · Cited by 47

Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure

Klinger, K., Gomes, F. V., Rincón-Cortés, M., & Grace, A. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.134 · Cited by 37

Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam

Du, Y., & Grace, A. A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw065 · Cited by 43

Dopamine System Dysregulation and the Pathophysiology of Schizophrenia: Insights From the Methylazoxymethanol Acetate Model

Grace, A. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.007 · Cited by 40

Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies

Potasiewicz, A., Hołuj, M., Litwa, E., Gzieło, K., Socha, L., Popik, P., & Nikiforuk, A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108040 · Cited by 39

Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice

Takahashi, K., Nakagawasai, O., Sakuma, W., Nemoto, W., Odaira, T., Lin, J.-R., Onogi, H., Srivastava, L. K., & Tan–No, K. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.034 · Cited by 37

Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats

Kučerová, J., Babinská, Z., Amchová, P., Štark, T., Drago, F., Šulcová, A., & Micale, V. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190032 · Cited by 38

Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis

Modinos, G., Kempton, M., Tognin, S., Calem, M., Porffy, L., Antoniades, M., Mason, A. J. C., Azis, M., Allen, P., Nelson, B., et al. (2019) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2019.3501 · Cited by 42

Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia

Sonnenschein, S. F., & Grace, A. A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.009 · Cited by 37

Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study

Modinos, G., McLaughlin, A. P., Egerton, A., McMullen, K., Kumari, V., Barker, G. J., Keysers, C., & Williams, S. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.53 · Cited by 36

Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms

Modinos, G., Şimşek, F., Horder, J., Bossong, M., Bonoldi, I., Azis, M., Perez, J., Broome, M., Lythgoe, D., Stone, J., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx076 · Cited by 32

Impaired contextual fear-conditioning in MAM rodent model of schizophrenia

Gill, K., Miller, S. A., & Grace, A. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.08.064 · Cited by 28

Using animal models for the studies of schizophrenia and depression: The value of translational models for treatment and prevention

Uliana, D. L., Zhu, X., Gomes, F. V., & Grace, A. A. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.935320 · Cited by 36

A Network Analysis of Epigenetic and Transcriptional Regulation in a Neurodevelopmental Rat Model of Schizophrenia With Implications for Translational Research.

Du, Y., Li, X.-S., Chen, L., Chen, G.-Y., & Cheng, Y. (2019) · Schizophrenia bulletin · doi:10.1093/schbul/sbz114 · Cited by 29

Protracted maturation of forebrain afferent connections of the ventral tegmental area in the rat

Yetnikoff, L., Reichard, R. A., Schwartz, Z. M., Parsely, K. P., & Zahm, D. S. (2014) · Journal of Comparative Neurology · doi:10.1002/cne.23459 · Cited by 30

Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model

Kaneko, G., Sanganahalli, B. G., Groman, S. M., Wang, H., Coman, D., Rao, J. U., Hermán, P., Jiang, L., Rich, K. M., de Graaf, R. A., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.019 · Cited by 30

State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia

Sonnenschein, S. F., Gill, K. M., & Grace, A. A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0219-1 · Cited by 32

Stress Exposure in Dopamine D4 Receptor Knockout Mice Induces Schizophrenia-Like Behaviors via Disruption of GABAergic Transmission

Tan, T., Wang, W., Williams, J., Ma, K., Cao, Q., & Yan, Z. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby163 · Cited by 29

Alterations in spatial memory and anxiety in the MAM E17 rat model of hippocampal pathology in schizophrenia

Gastambide, F., Taylor, A. M., Palmer, C. E., Svärd, H., Karjalainen, M., Janhunen, S. K., Tricklebank, M. D., & Bannerman, D. M. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3862-1 · Cited by 31

Are CB2 Receptors a New Target for Schizophrenia Treatment?

Cortez, I. L., da Silva, N. R., Guimarães, F. S., & Gomes, F. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587154 · Cited by 29

Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats

Potasiewicz, A., Hołuj, M., Piotrowska, D., Zajda, K., Wojcik, M., Popik, P., & Nikiforuk, A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.023 · Cited by 30

An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia

Chen, L., Perez, S. M., & Lodge, D. J. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22172 · Cited by 25

Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis

Sonnenschein, S. F., & Grace, A. A. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1849144 · Cited by 23

Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β

Xing, B., Han, G., Wang, M.-J., Snyder, M. A., & Gao, W. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.019 · Cited by 23

Hyperactive behavior in female rats in utero‐exposed to group B Streptococcus‐induced inflammation

Allard, M., Brochu, M., Bergeron, J. D., & Sebire, G. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.06.005 · Cited by 22

Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia

Bator, E., Latusz, J., Głowacka, U., Radaszkiewicz, A., Mudlaff, K., & Maćkowiak, M. (2018) · Neurotoxicity research · doi:10.1007/s12640-018-9888-0 · Cited by 18

The MAM-E17 schizophrenia rat model: Comprehensive behavioral analysis of pre-pubertal, pubertal and adult rats

Kállai, V., Tóth, A., Gálosi, R., Péczely, L., Ollmann, T., Petykó, Z., László, K., Kállai, J., Szabó, I., Karádi, Z., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.065 · Cited by 23

The mGluR2/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus

Sonnenschein, S. F., & Grace, A. A. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0764-2 · Cited by 20

GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia

Kiemes, A., Gomes, F. V., Cash, D., Uliana, D. L., Simmons, C., Singh, N., Vernon, A. C., Turkheimer, F., Davies, C., Stone, J. M., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01213-0 · Cited by 18

Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia.

Sonnenschein, S. F., & Grace, A. (2021) · Schizophrenia bulletin · doi:10.1093/schbul/sbab047 · Cited by 15

Update on current animal models for schizophrenia: are they still useful?

Uliana, D., Gomes, F. V., & Grace, A. (2023) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000854 · Cited by 11

Neurogenesis and Sensorimotor Gating: Bridging a Microphenotype and an Endophenotype

Osumi, N., Guo, N., Matsumata, M., & Yoshizaki, K. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303002834 · Cited by 15

Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review

Gee, A., Dazzan, P., Grace, A. A., & Modinos, G. (2025) · Translational Psychiatry · doi:10.1038/s41398-024-03221-2 · Cited by 13

Reduced cortical GABA and glutamate in high schizotypy

Kozhuharova, P., Diaconescu, A. O., & Allen, P. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05867-y · Cited by 12

Elevated glutamate, glutamine and GABA levels and reduced taurine level in a schizophrenia model using an in vitro proton nuclear magnetic resonance method.

Yang, J., Guo, H., Sun, D., Duan, J., Rao, X., Xu, F., Manyande, A., Tang, Y., Wang, J., & Wang, F. (2019) · PubMed Central · Cited by 11

Spirituality, religion, and psychotic disorders

Huguelet, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816766-3.00005-7 · Cited by 9

Aberrant Hippocampal Development in Early-onset Mental Disorders and Promising Interventions: Evidence from a Translational Study

Yang, J., Guo, H., Cai, A., Zheng, J., Liu, J., Xiao, Y., Ren, S., Sun, D., Duan, J., Zhao, T., et al. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01162-2 · Cited by 9

Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis

Livingston, N. R., Kiemes, A., Devenyi, G. A., Knight, S., Lukow, P. B., Jelen, L. A., Reilly, T. J., Dima, A., Nettis, M. A., Casetta, C., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01864-9 · Cited by 10

Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High Risk for Psychosis

Livingston, N. R., Micheli, A. D., McCutcheon, R. A., Butler, E., Hamdan, M., Grace, A. A., McGuire, P. K., Egerton, A., Fusar‐Poli, P., & Modinos, G. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae036 · Cited by 7

Effects of environmental enrichment on the activity of the amygdala in micrencephalic rats exposed to a novel open field

Matsuda, W., Ehara, A., Nakadate, K., Yoshimoto, K., & Ueda, S. (2017) · Congenital Anomalies · doi:10.1111/cga.12228 · Cited by 8

Animal Models of Relevance to the Schizophrenia Prodrome

Petty, A. E., Howes, O. D., & Eyles, D. W. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.12.001 · Cited by 8

Adult stress exposure blunts dopamine system hyperresponsivity in a neurodevelopmental rodent model of schizophrenia

Rincón-Cortés, M., & Grace, A. (2022) · Schizophrenia · doi:10.1038/s41537-022-00235-x · Cited by 8

Prefrontal Cortex Dysfunction as a Precipitating Factor for Schizophrenia and Depression

Uliana, D. L., & Grace, A. A. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70409 · Cited by 8

The ventral/anterior hippocampus as a central hub for stress-related dopaminergic circuit dysfunction in psychiatric disorders

Grace, A. A., & Uliana, D. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03513-7 · Cited by 5

Abnormalities in behavior relevant to schizophrenia in embryonic day 17 MAM-exposed rodent models: A systematic review and meta-analysis

Miao, Q., Zhu, P., Wang, H., He, Q., & Huo, C. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173888 · Cited by 6

What Can We Learn from Animal Models to Study Schizophrenia?

Crunfli, F., Brandão‐Teles, C., Zuccoli, G. S., Filho, A. J. M. C., Vieira, G. M., Silva-Amaral, D., Crippa, J. A. S., Pedrazzi, J. F. C., Macêdo, D. S., Bel, E. A. D., et al. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-97182-3_2 · Cited by 7

Towards an Integrated View of Early Molecular Changes Underlying Vulnerability to Social Stress in Psychosis

Barron, H., Hafizi, S., & Mizrahi, R. (2017) · Modern trends in psychiatry · doi:10.1159/000470810 · Cited by 7

GABA Dysfunction in Schizophrenia: The GABAA Receptor as a Potential Therapeutic Target

Crotchett, B. L. M., Reighard, S. D., & Nasrallah, H. A. (2025) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2025.100130 · Cited by 7

Short-term, but not long-term, beneficial effects of concomitant benzodiazepine use on clinical course in patients with schizophrenia

Ekinci, O., & Ekinci, A. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000392 · Cited by 5

Prenatal MAM treatment altered fear conditioning following social isolation: Relevance to schizophrenia

Bilecki, W., Latusz, J., Gawlińska, K., Chmelová, M., & Maćkowiak, M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113231 · Cited by 5

The Methylazoxymethanol Acetate Rat Model: Molecular and Epigenetic Effect in the Developing Prefrontal Cortex

Zhu, X., Gomes, F. V., & Grace, A. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14133 · Cited by 4

The antipsychotic agent sulpiride microinjected into the ventral pallidum restores positive symptom-like habituation disturbance in MAM-E17 schizophrenia model rats

Péczely, L., Dusa, D., Lénárd, L., Ollmann, T., Kertes, E., Gálosi, R., Berta, B., Szabó, Á., László, K., Zagorácz, O., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-63059-y · Cited by 4

Sex-dependent emergence of prepubertal social dysfunction and augmented dopamine activity in a neurodevelopmental rodent model relevant for schizophrenia

Rincón‐Cortés, M., & Grace, A. A. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.10.036 · Cited by 4

Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis

Livingston, N. R., Kiemes, A., O’Daly, O., Knight, S., Lukow, P. B., Jelen, L. A., Reilly, T. J., Dima, A., Nettis, M. A., Casetta, C., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725101268 · Cited by 3

Neurochemical models of psychosis risk and onset

Oliver, D., Modinos, G., & McGuire, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813201-2.00012-0 · Cited by 2

Use of prepubertal environment enrichment to prevent dopamine dysregulation in a neurodevelopmental rat model of schizophrenia risk

Zhu, X., & Grace, A. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101215 · Cited by 4

Dysregulation of Dopamine Systems in a Developmental Disruption Model of Schizophrenia

Dibble, S. M., Du, Y., & Grace, A. A. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00008-0 · Cited by 3

Congenital blindness does not protect against a schizophrenia-related phenotype in rodents

Perez, S. M., Elam, H. B., McCoy, A. M., Boley, A. M., Eassa, N. E., & Lodge, D. J. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.06.007 · Cited by 2

Insights from Proteomic Studies on Schizophrenia Preclinical Models: What Can We Learn for Drug Discovery?

Farrelly, L. A., Föcking, M., & Cotter, D. (2014) · Advances in biological psychiatry · doi:10.1159/000358028 · Cited by 2

Parvalbumin and anxiety across development in female offspring of the MAM neurodevelopmental model of schizophrenia

Gurgel, S. E., Kumaran, C., Uliana, D. L., & Grace, A. A. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.07.002 · Cited by 1

The MAM Model to Study the Role of Dopamine in Schizophrenia

Zhu, X., Uliana, D. L., & Grace, A. A. (2022) · Neuromethods · doi:10.1007/978-1-0716-2799-0_10 · Cited by 1

Early risk factors in early-onset psychosis

Karlsgodt, K. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89832-4.00003-2 · Cited by 1

The MAM-E17 neurodevelopmental model of schizophrenia

Maćkowiak, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817988-8.00050-6 · Cited by 2

Tratamento repetido com canabidiol atenua alterações comportamentais e moleculares em um modelo de esquizofrenia baseado no antagonismo dos receptores NMDA

Gomes, F. V. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2016.tde-05012016-224242

Can Psychosis Be Prevented by Treating Adolescent Anxiety

Geller, B. (2013) · Journal watch · doi:10.1056/nejm-jw.na31194

GABA A and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophreniaPreprint

Kiemes, A., Gomes, F. V., Cash, D., Uliana, D. L., Simmons, C., Singh, N., Vernon, A. C., Turkheimer, F., Davies, C., Stone, J. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.21.449343

Efeitos do levetiracetam sobre as alterações comportamentais e eletrofisiológicas tipo-esquizofrenia induzidas pela exposição ao estresse na adolescência

Cavichioli, A. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-06052022-144555

Intrinsic metabolic and immune impairments in a genetic mouse model of schizophrenia

Belmonte, M., Cardoso, S. L., Pietro, A. A. D., Veigas, F., Pasquini, L. A., & Gelman, D. M. (2025) · Schizophrenia · doi:10.1038/s41537-025-00651-9

Dopamine dysfunction in psychosis

McCutcheon, R. A., & Zauchenberger, C.-Z. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-29867-7.00035-9

Abberant anxiety in schizophrenia: A potential target for early intervention

Du, Y. (2015)

Aberrant anxiety in schizophrenia: a potential target for early intervention

Du, Y. (2016) · D-Scholarship@Pitt (University of Pittsburgh)

Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration

Du, Y., & Grace, A. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.42 · Cited by 59

S24. JUVENILITY AND ADOLESCENCE ARE CRITICAL PERIODS OF VULNERABILITY TO PSYCHOTOGENIC EFFECT OF STRESS: RELEVANCE TO SCHIZOPHRENIA

Zhu, X., Gomes, F. V., & Grace, A. A. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz020.569

The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention.

Grace, A., & Gomes, F. V. (2019) · Schizophrenia bulletin · doi:10.1093/schbul/sbx199 · Cited by 143